ArticleBlood2017
KRAS
Article in Blood, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 16 citations in OpenAlex.
- Histiocyte Society blueprint for Langerhans cell histiocytosis research: from cell-of-origin to a more comprehensive cure.Haematologica · 2025Review
- Statins mediate anti- and pro-tumourigenic functions by remodelling the tumour microenvironment.Disease models & mechanisms · 2022Article
- The coming of age of Langerhans cell histiocytosis.Nature immunology · 2020Article
- ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancer.EMBO molecular medicine · 2019Article
- Early detection of pre-malignant lesions in a KRASDisease models & mechanisms · 2019Article
- KRAS mutation in secondary malignant histiocytosis arising from low grade follicular lymphoma.Diagnostic pathology · 2018Article
- Afatinib restrains K-RAS-driven lung tumorigenesis.Science translational medicine · 2018Article
- The ERBB network facilitates KRAS-driven lung tumorigenesis.Science translational medicine · 2018Article
- Approaches to Evaluate Lung Inflammation in Translational Research.Veterinary pathology · 2018Review
Corrections and comments
- Commented on byKRAS2017
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Langerhans cell histiocytosis (LCH) is a rare histiocytic neoplasm associated with somatic mutations in the genes involved in the RAF/MEK/extracellular signal-regulated kinase (ERK) signaling pathway. Recently, oncogenic mutations in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.